Berlin named director of Division of Hematology and Oncology
Jordan Berlin, MD, Ingram Professor of Cancer Research, has been named director of Vanderbilt’s Division of Hematology and Oncology.
Researchers clarify role of blood cell mutations in disease
More than 10% of older adults develop somatic (non-inherited) mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells, increasing the risk for blood cancer and cardiovascular disease. Multiple DNA sequencing methods have been used to identify what is called “clonal hematopoiesis of indeterminate potential,” or CHIP, but it has been difficult to distinguish true mutations from artifacts.
New treatment helps mitigate hair loss for chemotherapy patients
Vanderbilt-Ingram Cancer Center has started offering scalp cooling, which mitigates hair loss for patients receiving certain chemotherapy regimens.
The DigniCap Scalp Cooling System was launched this month at Vanderbilt-Ingram Cancer Center Belle Meade. It is available for patients with solid tumors from breast cancer, prostate cancer, ovarian cancer, uterine cancer and lung cancer.
VUMC researcher selected for Global Scholars Program
Vanderbilt researcher P. Brent Ferrell, MD, is leading one of five projects selected by the 2022 NIBR (Novartis Institutes for BioMedical Research) Global Scholars Program.
Osterman named Associate Vice President for Research Informatics
Travis Osterman, DO, MS, assistant professor of Biomedical Informatics (DBMI), Hematology and Oncology and director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center (VICC), has been appointed to a new role as Associate Vice President for Research Informatics at Vanderbilt University Medical Center.
Nicole Kidman and Keith Urban gift supports breast cancer clinical trials at Vanderbilt-Ingram Cancer Center
Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.
The Oscar-winning and Grammy-winning international cinema and music superstars have been longtime cancer research supporters. They live in Nashville, home of Vanderbilt-Ingram, which has internationally recognized breast cancer researchers and clinicians.
Eng stresses need for clinical trial support at cancer forum
Cathy Eng, MD, the David H. Johnson Professor of Surgical and Medical Oncology, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum on Friday, March 10.
Trial combines novel therapies for head and neck cancer
Vanderbilt-Ingram Cancer Center is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.
Four elected to the American Academy of Arts & Sciences
Kimryn Rathmell, MD, PhD, MMHC, chair of the Department of Medicine at Vanderbilt University Medical Center, is one of four Vanderbilt University faculty members elected this year to the American Academy of Arts & Sciences.
Liquid biopsy test may detect early-stage and low DNA-shedding cancers
A liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers, according to data from a retrospective study presented at the AACR Annual Meeting 2023, held recently in Orlando, Florida.